Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
Kim
W
W
Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea.
Lee
S
S
Kang
S K
SK
Yu
H C
HC
Cho
B H
BH
Park
S K
SK
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy; D011188:Potassium / Q000097:blood; D011507:Proteinuria; D044140:Receptor, Angiotensin, Type 1; D014527:Uric Acid / Q000097:blood
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D044140:Receptor, Angiotensin, Type 1; D014527:Uric Acid; D004656:Enalapril; D003404:Creatinine; D019808:Losartan; D011188:Potassium